An open-label pilot study of the efficacy and tolerability of once-daily didanosine versus twice-daily didanosine.
University of Texas Southwestern Medical Center at Dallas, USA.
P
P
Keiser
D
D
Turner
O
O
Ramilo
M B
MB
Kvanli
J W
JW
Smith
N
N
Nassar
D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D016049:Didanosine / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010865:Pilot Projects; D019562:Viral Load
D019380:Anti-HIV Agents; D016049:Didanosine